| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $75.4M | +8.0% |
| Cost of Revenue | $101.1M | -29.0% |
| Gross Profit | -$25.7M | +64.7% |
| R&D Expense | $231.7M | -11.6% |
| SG&A Expense | $115.8M | -27.6% |
| Operating Income | -$435.0M | +22.8% |
| Pre-tax Income | -$273.9M | +51.9% |
| Income Tax | -$743K | -143.8% |
| Net Income | -$273.1M | +52.2% |
| EPS (Basic) | -$8.70 | -491.8% |
| EPS (Diluted) | -$8.70 | -491.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $82.8M | -40.4% |
| Accounts Receivable | $14.3M | +1.0% |
| Inventory | $14.9M | +22.2% |
| Current Assets | $245.2M | -30.1% |
| Total Assets | $365.2M | -28.7% |
| Current Liabilities | $60.6M | -27.8% |
| Long-term Debt | $500.5M | -18.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$276.6M | -11.9% |
| Capital Expenditures | $5.1M | -76.8% |
| Investing Cash Flow | $42.5M | -82.1% |
| Financing Cash Flow | $178.3M | +122.3% |
| Free Cash Flow | -$281.7M | -4.6% |
| Total Liabilities |
| $586.0M |
| -20.5% |
| Stockholders' Equity | -$220.8M | +1.8% |